HAISCO PHARMACEUTI financial statements, including revenue, expenses, profit, and loss

The total revenue of 002653 for the last quarter is 1.05 B CNY, and it's 13.94% higher compared to the previous quarter. The net income of Q3 24 is 217.10 M CNY.